2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.

Hugh Calkins , Gerhard Hindricks , Riccardo Cappato , Young-Hoon Kim , Eduardo B Saad , Luis Aguinaga , Joseph G Akar , Vinay Badhwar , Josep Brugada , John Camm , Peng-Sheng Chen , Shih-Ann Chen , Mina K Chung , Jens Cosedis Nielsen , Anne B Curtis , D Wyn Davies , John D Day , André d'Avila , N M S Natasja de Groot , Luigi Di Biase

Heart Rhythm

Jikei University School of Medicine, Tokyo, Japan.

Published: October 2017

Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.hrthm.2017.07.009	DOI Listing

Publication Analysis

Top Keywords

2017 hrs/ehra/ecas/aphrs/solaece

hrs/ehra/ecas/aphrs/solaece expert

expert consensus

consensus statement

statement catheter

catheter surgical

surgical ablation

ablation atrial

atrial fibrillation

fibrillation executive

Similar Publications

Uninterrupted anticoagulation with non-vitamin K antagonist oral anticoagulants in atrial fibrillation catheter ablation: Lessons learned from randomized trials.

Clin Cardiol

January 2019

Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland.

Rhanderson Cardoso , Stephan Willems , Edward P Gerstenfeld , Atul Verma , Richard Schilling

Catheter ablation has been established as a rhythm control strategy in selected patients with atrial fibrillation (AF) who have failed or wish to avoid anti-arrhythmic drugs. Uninterrupted oral anticoagulation with vitamin K antagonists (VKAs) peri-ablation is associated with a lower risk of thromboembolic and bleeding complications as compared to interrupted oral anticoagulation and bridging heparin. However, a substantial portion of patients with AF are treated with non-vitamin K antagonist oral anticoagulants (NOACs).

View Article and Find Full Text PDF

Similar Publications